Clinical Trials Browser

Phase 3 × Colonic Neoplasms × 1 year × Clear all

NCT00217737 2026-03-18

Oxaliplatin, Leucovorin, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer

Phase 3 Active not recruiting

2,431 enrolled 13 charts

Gastrointestinal

Colonic Neoplasms

NCT07284849 2026-03-16

A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer

Phase 3 Recruiting

Gastrointestinal

Colonic Neoplasms, Colorectal Neoplasms

NCT00905047 2026-03-13

COLOCROSS

Phase 3 Completed

Gastrointestinal

Colonic Neoplasms, Neoplasm Metastasis, Colorectal Neoplasms

NCT01918527 2026-03-10

Neoadjuvant Chemotherapy Versus Standard Treatment in Patients With Locally Advanced Colon Cancer

Phase 3 Active not recruiting

Gastrointestinal

Colonic Neoplasms

NCT00102011 2026-03-09

00-046

Phase 3 Completed

Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT06446557 2026-02-20

DIAMOND

Phase 3 Not yet recruiting

Gastrointestinal

Colonic Neoplasms

NCT01460589 2026-02-12

ECTX

Phase 3 Active not recruiting

Gastrointestinal

Colonic Neoplasms

NCT03426904 2026-02-11

Neoadjuvant FOLFOX Chemotherapy for Patients With Locally Advanced Colon Cancer

Phase 3 Active not recruiting

Gastrointestinal

Colonic Neoplasms

NCT06563388 2026-02-04

ID-COMET

Phase 3 Recruiting

GastrointestinalGenitourinaryThoracic

Colonic Neoplasms, Lung Neoplasms, Prostatic Neoplasms

NCT02912559 2026-02-02

Combination Chemotherapy With or Without Atezolizumab in Treating Patients With Stage III Colon Cancer and Deficient DNA Mismatch Repair

Phase 3 Active not recruiting

Gastrointestinal

Colonic Neoplasms, Colorectal Neoplasms, Hereditary Nonpolyposis, DNA Repair-Deficiency Disorders

NCT05177484 2026-01-30

PICoC

Phase 3 Completed

40 enrolled 19 charts

Gastrointestinal

Colonic Neoplasms

NCT07222800 2026-01-30

A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer

Phase 3 Recruiting

Gastrointestinal

Colonic Diseases, Colonic Neoplasms, Digestive System Diseases, Digestive System Neoplasms, Gastrointestinal Diseases, Gastrointestinal Neoplasms, Intestinal Diseases, Intestinal Neoplasms, Neoplasm Metastasis, Neoplasms by Site, Rectal Diseases, Colorectal Neoplasms

NCT05855200 2026-01-23

Study of Perioperative Dostarlimab in Participants With Untreated T4N0 or Stage III dMMR/MSI-H Resectable Colon Cancer

Phase 3 Recruiting

Gastrointestinal

Colonic Neoplasms

NCT00002968 2025-12-29

Edrecolomab in Treating Patients With Stage II Colon Cancer

Phase 3 Completed

Gastrointestinal

Colonic Neoplasms

NCT03803553 2025-12-23

Identification and Treatment Of Micrometastatic Disease in Stage III Colon Cancer

Phase 3 Recruiting

Gastrointestinal

Colonic Neoplasms

NCT06686576 2025-12-18

A Study of Neoadjuvant QL1706 in Participants With Untreated dMMR/MSI-H Resectable Colon Cancer

Phase 3 Recruiting

Gastrointestinal

Colonic Neoplasms

NCT06940947 2025-11-20

ETHOS

Phase 3 Recruiting

Gastrointestinal

Colonic Neoplasms

NCT02967289 2025-11-17

IROCAS

Phase 3 Completed

Gastrointestinal

Colonic Neoplasms, Neoplasms

NCT01727388 2025-09-19

RIFIONA

Phase 3 Completed

Gastrointestinal

Colonic Neoplasms, Diverticulitis, Gastrointestinal Hemorrhage, Hernia, Rectal Neoplasms, Colorectal Neoplasms

NCT04534075 2025-09-08

FIDURA

Phase 3 Completed

GastrointestinalGenitourinaryGynecologic

Anus Neoplasms, Urinary Bladder Neoplasms, Uterine Cervical Neoplasms, Colonic Neoplasms, Flatulence, Neoplasms, Ovarian Neoplasms, Prostatic Neoplasms, Rectal Neoplasms

NCT06490536 2025-08-29

The Sagittarius Trial

Phase 3 Recruiting

Gastrointestinal

Colonic Neoplasms

NCT07132008 2025-08-20

Neoadjuvant CAPOX Plus Tislelizumab vs CAPOX in MSS High-Risk Locally Advanced Colon Cancer

Phase 3 Not yet recruiting

Gastrointestinal

Colonic Neoplasms

NCT04607421 2025-08-14

A Study of Encorafenib Plus Cetuximab With or Without Chemotherapy in People With Previously Untreated Metastatic Colorectal Cancer

Phase 3 Active not recruiting

831 enrolled 2 FDA

Gastrointestinal

Colonic Diseases, Colonic Neoplasms, Digestive System Diseases, Digestive System Neoplasms, Gastrointestinal Diseases, Gastrointestinal Neoplasms, Intestinal Diseases, Intestinal Neoplasms, Neoplasms, Rectal Diseases, Rectal Neoplasms, Colorectal Neoplasms

NCT06208371 2025-05-30

Localized Treatment Versus Palliative Chemotherapy in CRC Patients With 10 or More CRLM

Phase 3 Recruiting

Gastrointestinal

Colonic Neoplasms

NCT05482516 2025-05-22

MRD-GI

Phase 3 Recruiting

Gastrointestinal

Colonic Neoplasms, Carcinoma, Hepatocellular, Rectal Neoplasms

NCT02467582 2025-05-16

Adjuvant Aspirin Treatment for Colon Cancer Patients

Phase 3 Terminated

1,040 enrolled 11 charts

Gastrointestinal

Colonic Neoplasms, Hereditary Sensory and Autonomic Neuropathies

NCT03428477 2025-04-18

EMT2

Phase 3 Active not recruiting

Gastrointestinal

Colonic Neoplasms

NCT04322539 2025-04-04

FRESCO-2

Phase 3 Completed

691 enrolled 26 charts 1 FDA

Gastrointestinal

Colonic Neoplasms, Colorectal Neoplasms

NCT06899477 2025-03-28

Pre-Operative Treatment in REseCTable COlon CanceR

Phase 3 Not yet recruiting

Gastrointestinal

Colonic Neoplasms

NCT02572141 2025-03-19

OPTICAL

Phase 3 Active not recruiting

Gastrointestinal

Colonic Neoplasms